Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Andrology. 2013 Mar 15;1(3):475–482. doi: 10.1111/j.2047-2927.2013.00075.x

The Effect of Testosterone on Mood and Well-being in Men with Erectile Dysfunction in a Randomized, Placebo-Controlled Trial

Table Baseline Demographics, Well-Being and Mood
Demographics Testosterone
(n=70)
Placebo
(n=70)
    Age (years) 55.1 (8.3) 54.6 (8.5)
    Race – no. (%)
        Black 28 (41%) 33 (47%)
       White 36 (53%) 32 (46%)
        Other 4 (6%) 5 (7%)
    Body Mass Index (kg/m2) 31.5 (6.4) 32.7 (6.0)
    Diabetes Mellitus – no. (%) 13 (21%) 14 (22%)
    Hypertension – no. (%) 29 (45%) 27 (40%)
    Cardiovascular Disease – no. (%) 35 (50%) 32 (46%)
    Serum Testosterone
        Total Testosterone (ng/dL) 248 (62) 254 (68)
Psychological General Well-Being Index Score (%)
    Positive Well-being 62 (17) 61 (19)
    Depressed Mood 86 (14) 83 (15)
    General Health 73 (16) 73 (17)
    Anxiety 75 (15) 72 (18)
    Self Control 85 (13) 84 (14)
    Global Score 73 (12) 72 (14)
Derogatis Affects Balance Scale Dimension
    Joy 13.0 (3.2) 12.9 (4.3)
    Contentment 13.1 (2.9) 12.8 (3.6)
    Vigor 12.2 (3.2) 12.3 (4.1)
    Affection 14.4 (3.6) 14.2 (3.8)
    Depression 3.9 (3.3) 4.7 (3.7)
    Anxiety 5.4 (3.5) 6.2 (3.1)
    Guilt 4.1 (3.7) 4.4 (3.9)
    Hostility 4.5 (3.5) 4.8 (3.7)

Baseline characteristics are displayed as mean (standard deviation). Scores are reported prior to receipt of sildenafil, testosterone or placebo. Psychological General Well-Being Index scores may range from 0 to 100%, with higher scores reflecting improved well-being. Derogatis Affects Balance Scale dimension scores may range from 0 to 20, with higher scores reflecting greater affectivity of the respective dimension.